The South London and Maudsley NHS Foundation Trust provides the widest range of NHS mental health services in the UK. It operates in partnership the King’s College London’s Institute of Psychiatry, which is Europe’s largest centre for research in psychiatry, psychology, basic and clinical neuroscience. Together they house the only mental health specific NIHR Biomedical Research Centre in the UK.
Partners
Founded in 1851 The Royal Marsden was the first hospital in the world dedicated to the study and treatment of cancer. Today it undertakes groundbreaking research into new cancer drug therapies and treatments in partnership with The Institute of Cancer Research. Together they form the largest cancer centre in Europe and house the only cancer specific NIHR Biomedical Research Centre in the UK.
GlaxoSmithKline (GSK) is one of the world’s leading research-based pharmaceutical and healthcare companies with a track record of turning research into marketable drugs. It is a global organization headquartered in the UK, with offices in over 100 countries and major research centres in the UK, USA, Belgium and China.
Pfizer is a leading pharmaceutical company that maximizes new opportunities in biomedical research to bring more innovative medicines to patients. With over 150 years of experience and a large research base it is well equipped to push the boundaries of medical research.
GE Healthcare provides medical technologies and services that are shaping a new age of patient care and help clinicians around the world to predict, diagnose and monitor diseases. Headquartered in the United Kingdom GE Healthcare operates in more than 100 countries worldwide.
The Monitor Group is a global management consulting firm with unparalleled expertise in cluster development and broad experience of working with leading corporations and governments around the world to facilitate growth.
Reed Smith has a long standing reputation for successfully representing global life science and health care companies in complex corporate and regulatory matters, key transactions, and high profile litigation.